Login
+44 203 371 1100
Login
+44 203 371 1100
Credit Sector:- Health Care
Country:- United States
Bond Document:- https://www.bondpdf.com
In order to view the complete data, please login here
| Announcement Date | CA Type | CA Impact | CA Event | ISIN |
|---|---|---|---|---|
| 09-May-2018 | Class Action | - | - | US00214WAE12 |
| Gilead Sciences, Inc. today announced that the class action lawsuit has been filed against the company. | ||||
| 07-Feb-2018 | Legal Action | - | - | US00214WAE12 |
| Gilead Sciences, Inc. announced today that a legal action has been filed against the company. | ||||
| 14-May-2019 | Class Action | - | - | US00214WAE12 |
| Gilead Sciences, Inc. today announced that some of the consumers has files antitrust complaint in federal court in San Francisco against the company. | ||||
| 07-Dec-2017 | Propose Acquisition | Target Name | Cell Design Labs, Inc. | US00214WAE12 |
| Gilead Sciences, Inc. and Kite Pharma Inc. announced today that they have entered into a definitive agreement to acquire Cell Design Labs, Inc. | ||||
| 28-Aug-2017 | Propose Acquisition | Target Name | Kite Pharma Inc. | US00214WAE12 |
| Gilead Sciences, Inc. announced today that it has signed an agreement to acquire Kite Pharma Inc. | ||||
All of the financial data available on this page is sourced from FactEntry.